"They can argue that they didn't have a final diagnosis to point to and a treatment regimen in place, and I can buy that to a degree," McGurn said. "But the fact of the matter is that there was a prior history here. This is not the first time Apple has gone through this drill. It should have just bitten the bullet and announced it would provide regular updates on Steve Jobs' health because the company knows the issue is important to investors."
Advertisement
The prognosis for Apple's Steve Jobs: continuing conjecture
The cancer survivor tells worried fans and investors that a hormone imbalance has caused his weight loss.
For The Record
Los Angeles Times Thursday, January 08, 2009 Home Edition Main News Part A Page 2 National Desk 1 inches; 36 words Type of Material: Correction
Steve Jobs: An article in Section A on Tuesday about the health of Apple Chief Executive Steve Jobs said Times staff writer Dawn C. Chmielewski was reporting from Los Angeles. She was reporting from San Francisco.
Advertisement
Wall Street heaved a sigh of relief Monday. Apple's shares gained $3.83 to $94.58.
"Lack of information is the worst thing for investors," said Michael Obuchowski, chief investment officer of First Empire Asset Management Inc., which holds Apple stock. "This made Apple investors very happy."
Adam Harter, an analyst at Financial Enhancement Group, which owns more than 30,000 shares, reacted more cautiously.
"I am not a doctor, but it certainly doesn't give you the comfort that nothing is wrong with him."
--
dawn.chmielewski@latimes.com
jessica.guynn@latimes.com
Times staff writer Shari Roan contributed to this report.
